OpGen appoints David Lazar as CEO with deferred salary and concurrent CEO roles

CapForce Inc.

David Lazar, age 33, appointed CEO effective April 1, 2024; also serves as Chairman of the Board.
Base salary $406,000 per annum, fully deferred until Compensation Committee determines sufficient liquidity.
Three-year term; Lazar concurrently serves as CEO of Titan Pharmaceuticals (TTNP) and Minim, Inc. (MINM).
Annual bonus at 100% base salary; special bonus: 3% of change-in-control valuation increase, $203k per $1M+ capital raise.
Severance includes salary continuation for 12 months or remaining term, medical reimbursement, prorated bonus, accelerated vesting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.